258 related articles for article (PubMed ID: 19348841)
1. Contrast-induced nephropathy: are there differences between low osmolar and iso-osmolar iodinated contrast media?
Morcos SK
Clin Radiol; 2009 May; 64(5):468-72. PubMed ID: 19348841
[TBL] [Abstract][Full Text] [Related]
2. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W
Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279
[TBL] [Abstract][Full Text] [Related]
3. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
Fishman EK; Reddan D
Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
[TBL] [Abstract][Full Text] [Related]
4. Comparative cytotoxicity of high-osmolar and low-osmolar contrast media on HKCs in vitro.
Duan S; Zhou X; Liu F; Peng Y; Chen Y; Pei Y; Ling G; Zhou L; Li Y; Pi Y; Tang K; Liu R; Li G
J Nephrol; 2006; 19(6):717-24. PubMed ID: 17173243
[TBL] [Abstract][Full Text] [Related]
5. Nephrotoxicity related to contrast media.
Berg KJ
Scand J Urol Nephrol; 2000 Oct; 34(5):317-22. PubMed ID: 11186471
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality.
Rudnick MR; Goldfarb S
Rev Cardiovasc Med; 2003; 4 Suppl 5():S28-33. PubMed ID: 14668707
[TBL] [Abstract][Full Text] [Related]
7. Comparative effect of iso-osmolar versus low-osmolar contrast media on the incidence of contrast-induced acute kidney injury in diabetic patients: a systematic review and meta-analysis.
Zhao F; Lei R; Yang SK; Luo M; Cheng W; Xiao YQ; Li XW; Guo J; Duan SB
Cancer Imaging; 2019 Jun; 19(1):38. PubMed ID: 31215488
[TBL] [Abstract][Full Text] [Related]
8. Contrast-induced nephropathy: the wheel has turned 360 degrees.
Thomsen HS; Morcos SK; Barrett BJ
Acta Radiol; 2008 Jul; 49(6):646-57. PubMed ID: 18568557
[TBL] [Abstract][Full Text] [Related]
9. Comparative tolerability of contrast media used for coronary interventions.
Esplugas E; Cequier A; Gomez-Hospital JA; Del Blanco BG; Jara F
Drug Saf; 2002; 25(15):1079-98. PubMed ID: 12452733
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media.
McCullough PA; Bertrand ME; Brinker JA; Stacul F
J Am Coll Cardiol; 2006 Aug; 48(4):692-9. PubMed ID: 16904536
[TBL] [Abstract][Full Text] [Related]
11. Major Adverse Renal and Cardiovascular Events following Intra-Arterial Contrast Media Administration in Hospitalized Patients with Comorbid Conditions.
McCullough P; Ng CS; Ryan M; Baker ER; Mehta R
Cardiorenal Med; 2021; 11(4):193-199. PubMed ID: 34433166
[TBL] [Abstract][Full Text] [Related]
12. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
Solomon R; Dumouchel W
Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
[TBL] [Abstract][Full Text] [Related]
13. [Iodinated contrast media and nephropathy. Estimated creatinine clearance for better assessment of renal function and dosage].
Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
Ugeskr Laeger; 2004 Jun; 166(26-31):2566-72. PubMed ID: 15285166
[No Abstract] [Full Text] [Related]
14. Clinical inquiries. What interventions reduce the risk of contrast nephropathy for high-risk patients?
Grossman PD; Burroughs M; Guthmann RA
J Fam Pract; 2005 Apr; 54(4):365-7. PubMed ID: 15833230
[TBL] [Abstract][Full Text] [Related]
15. [Iodinated contrast media and nephropathy--new recommendations. Estimated creatine clearance for better assessment of renal function and dosage].
Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
Lakartidningen; 2003 Mar; 100(10):840-3, 846-8. PubMed ID: 12680021
[No Abstract] [Full Text] [Related]
16. Contrast medium use.
Davidson C; Stacul F; McCullough PA; Tumlin J; Adam A; Lameire N; Becker CR;
Am J Cardiol; 2006 Sep; 98(6A):42K-58K. PubMed ID: 16949380
[TBL] [Abstract][Full Text] [Related]
17. Recent issues in contrast-induced nephropathy.
Kitajima K; Maeda T; Watanabe S; Sugimura K
Int J Urol; 2011 Oct; 18(10):686-90. PubMed ID: 21834851
[TBL] [Abstract][Full Text] [Related]
18. Re: contrast-induced nephropathy: are there differences between low osmolar and iso-osmolar iodinated contrast media?
Downes MO; Nicholson A
Clin Radiol; 2010 Apr; 65(4):343-4; author reply 344-5. PubMed ID: 20338404
[No Abstract] [Full Text] [Related]
19. Strategies to reduce the risk of contrast nephropathy: an evidence-based approach.
Pannu N; Tonelli M
Curr Opin Nephrol Hypertens; 2006 May; 15(3):285-90. PubMed ID: 16609296
[TBL] [Abstract][Full Text] [Related]
20. The safety and cost-effectiveness of low osmolar contrast media. Can economic analysis determine the real worth of a new technology?
Henry DA; Evans DB; Robertson J
Med J Aust; 1991 Jun; 154(11):766-72. PubMed ID: 1828529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
